Friday, July 15, 2011 7:18:53 PM
The Q ending in August tends to be the biggest sequential sales jump for the company each time in the last 4 years. That plus the FDA approval suggests we could see a killer quarter, I'm thinking .02 EPS
So Qs ending Aug and Nov should/could/hope be the start of the long awaited .02/.03 Qs I've expecting which brings an annualized rate of .10 or so and justifiable triple digit stock price. ($1.50+ ?)
Raw
Research & analysis on some of my favorite stocks is located on the sticky note on the SwingTrade board.
http://investorshub.advfn.com/boards/board.aspx?board_id=1781
FEATURED DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • Nov 7, 2024 2:16 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM